Zelix

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zelix

Quick Facts: Zelix (Fluconazole)

Property Description
Active ingredient Fluconazole (INN)
Primary Forms Capsule, Tablet, Oral Suspension, Intravenous Solution
Pharmacological Class Systemic Antifungal Agent, Triazole Derivative
General Purpose Controlling fungal infections (mycoses)
Origin Synthetic Compound

What is Zelix and What is its Active Ingredient?

Zelix is a synthetic prescription-only medication whose active component is the antifungal agent Fluconazole (INN). It is classified as a Systemic Antifungal Agent, belonging to the azole family of antimycotics and further categorized as a triazole derivative. As a synthetic compound, Fluconazole is not naturally occurring; it is precisely engineered to combat fungal pathogens. The formulation is clinically recognized for its high oral absorption, a key pharmacological feature distinguishing it from some older antifungal agents.

The definitive mechanism of Fluconazole is the selective inhibition of a key fungal enzyme, 14alpha-demethylase, which prevents the fungus from synthesizing ergosterol, a vital component of its cell membrane. This means that Zelix has a highly targeted effect on fungal organisms, helping to stop their growth without harming human cells.


What is the General Purpose of Zelix?

The general purpose of Zelix is to control and neutralize the growth of various fungal infections (mycoses) within the body. Its action is primarily fungistatic, meaning it works by halting the reproduction of the fungal organisms, allowing the body’s immune system to clear the existing infection.

This targeted action is essential for managing deep-seated or widespread mycoses. Clinical guidance confirms that Fluconazole is widely utilized for treating a broad array of serious fungal diseases, establishing its recognized role as a versatile systemic agent. The conclusion drawn is that the medicine serves as a critical defense against systemic fungal pathogens.


In What Forms is Zelix Available?

Zelix is available in several dosage forms suitable for systemic delivery, including Capsules, Tablets, an Oral Suspension, and an Intravenous Solution. These forms collectively support the delivery of Fluconazole via both the oral and parenteral routes of administration.

The availability of multiple forms is a key feature, providing necessary flexibility in treatment. The formulation is often characterized by a pleasant flavor in its Oral Suspension form, which facilitates easier administration for pediatric patients or individuals with difficulty swallowing. The intravenous form ensures rapid and complete systemic delivery of the active ingredient, which is crucial in managing severe infections.

What side effects are possible with Zelix?

Possible Side Effects and Safety Information

The safety profile of Zelix (Fluconazole) is documented in official regulatory sources, with adverse reactions classified by frequency and the physiological system affected.

Common adverse reactions, occurring in 1% to 10% of patients, typically involve Gastrointestinal disorders such as abdominal pain, nausea, vomiting, and diarrhea, along with Headache and increases in certain liver enzymes. Uncommon effects include dizziness, constipation, dry mouth, skin reactions like rash or hives, and blood disorders such as anemia.

Classification System-Organ Class Examples
Common Gastrointestinal, Nervous System, Hepatobiliary
Uncommon Nervous System, Skin, Blood & Lymphatic System

Serious Adverse Reactions are rare but clinically significant and are explicitly documented. These include severe Hepatotoxicity that may progress to liver failure, severe Exfoliative Cutaneous Reactions (such as Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis), and rare Cardiac events, specifically QT interval prolongation and Torsade de pointes. Anaphylaxis is also listed as a rare, severe hypersensitivity reaction. The severity of hepatic and cutaneous reactions is not clearly related to the duration of therapy.

Population-Specific Safety: Caution is advised for patients with existing Renal or Hepatic Impairment, as Fluconazole is eliminated primarily by the kidneys, and the drug is associated with rare hepatotoxicity. Official regulatory notes state that the use of high doses during the first trimester of pregnancy has been linked to an increased risk of congenital anomalies.

Overdose and Emergency Response

Overdose and when to seek help

Taking more than the recommended dose of this medication poses a risk of serious, potentially fatal adverse events, primarily affecting the heart and central nervous system. These risks are heightened when the drug is used in quantities significantly above the maximum recommended daily limit.

Documented Overdose Symptoms

Official regulatory information identifies specific overdose presentations, which require immediate medical intervention:

System Affected Key Manifestations
Cardiovascular QTc interval prolongation, Torsades de Pointes, ventricular arrhythmias, syncope, cardiac arrest, death.
Central Nervous System (CNS) Stupor, somnolence, unresponsiveness, confusion, miosis (pinpoint pupils), muscular hypertonia.
Respiratory Respiratory depression (slow, shallow breathing), breathing difficulties.
Gastrointestinal Paralytic ileus (bowel blockage), severe constipation, abdominal distension.

Emergency Action

Immediate emergency medical attention must be sought if an overdose is suspected or if symptoms such as a fast, irregular, or pounding heartbeat, dizziness, unresponsiveness, or trouble breathing occur. Naloxone may be administered as an antidote, but since the effect of the drug is long-lasting, repeated naloxone treatment may be necessary. Patients must be monitored closely in a healthcare setting for at least 48 hours for signs of CNS or cardiac depression. For acute overdose (within 2–4 hours), administering activated charcoal may be considered by a healthcare professional.

Therapeutic Uses of Zelix

Zelix (Fluconazole) is commonly used to address a wide array of fungal conditions. This medication may assist with providing symptomatic support in situations where patients experience discomfort from fungal overgrowth. This therapeutic agent plays a role in managing infections primarily caused by Candida and Cryptococcus species.


Main Therapeutic Uses and Benefits

Zelix is applied in clinical settings that involve acute or unstable symptom patterns from serious, systemic fungal diseases, including candidemia (fungus in the bloodstream) and cryptococcal meningitis (brain lining infection). It is also commonly used across conditions presenting with localized discomfort, such as oropharyngeal and esophageal candidiasis (thrush), and acute or recurrent vulvovaginal candidiasis (yeast infections). This medication is relevant when supportive symptom management is appropriate for high-risk groups, such as those with neutropenia, or to help prevent the relapse of certain severe infections.

This supportive medication assists with maintaining a sense of stability during challenging systemic and localized infections. This therapeutic approach focuses on supporting the management of the infection, which contributes to easing the overall symptom load, such as persistent fever and intense localized itching, and helps improve day-to-day comfort.


Quick Fact: Relief for Fungal Discomfort

Symptom Domain Conditions Managed Patient Benefit
Systemic Distress Candidemia, Cryptococcal Meningitis Assists with maintaining systemic stability
Localized Irritation Thrush, Vaginal Candidiasis Supports relief of noticeable itching and swallowing difficulty
Infection Risk Neutropenia, Recurrent Episodes Supports management of relapse risk

Regulatory References

  1. MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Zelix?

This section outlines the official population eligibility rules for Zelix (Fluconazole), as defined by governmental regulatory agencies.


Contraindications (Absolute Prohibition)

Zelix is contraindicated in populations with a known hypersensitivity to fluconazole or its inactive ingredients. Absolute prohibition also applies to patients receiving co-administration of specific QT-prolonging medicines that are metabolized by the CYP3A4 enzyme (e.g., cisapride, pimozide). Additionally, individuals with rare hereditary metabolic disorders, such as Lapp lactase deficiency, must not use the formulation containing those excipients.


Age and Condition Restrictions

Use of Zelix is established across most age groups, from infants (with adjusted dosing) to adults. However, use in older adults is conditional on assessing renal function.

Specific caution or restrictions apply to patients with:

  • Impaired Renal Function: Requires mandatory dose adjustment for multiple-dose therapy.
  • Hepatic Impairment: Requires cautious administration and close monitoring.
  • Cardiac Conditions: Restricted use in patients with potentially proarrhythmic conditions or severe electrolyte abnormalities.

Pregnancy and Lactation Status

The medicine is not recommended for use during pregnancy unless clearly necessary, and high-dose/prolonged regimens are generally contraindicated. Breastfeeding is not recommended following repeated or high-dose therapy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Zelix (Fluconazole) exhibits specific interaction patterns documented in governmental regulatory sources. The medication is officially designated as a potent inhibitor of the CYP2C9 enzyme and a moderate inhibitor of CYP3A4 and CYP2C19. This established metabolic action can lead to elevated systemic exposure of co-administered medicines metabolized by these enzymes, such as certain statins, which increases the documented risk of rhabdomyolysis and myopathy.

Contraindicated Combinations and High-Risk Interactions

Co-administration is strictly contraindicated with several substances due to the high risk of QT prolongation and cardiotoxicity resulting from increased plasma levels. These prohibited combinations include Astemizole, Cisapride, Pimozide, Quinidine, and Erythromycin. The restriction for Terfenadine is formally dose-dependent, applying only when Zelix is administered at 400 mg per day or greater. The interaction with Warfarin (a Coumarin-type anticoagulant) is officially noted to increase Prothrombin Time, heightening the risk of bleeding events.

Exposure Modifiers and Substance Restrictions

Other substances can alter the systemic exposure of Fluconazole itself. Regulatory documents state that Rifampicin is documented to reduce Fluconazole systemic exposure, while Hydrochlorothiazide is noted to increase it by 40%. The drug’s pharmacokinetics are also markedly affected by reduced renal function, which necessitates consideration when co-administering other agents. Regarding substance interactions, the official label advises avoidance of alcohol due to the potential for increased liver risk. Administration with or without food has no clinically significant effect on the absorption of Zelix.

Mechanism of Action

How Zelix Works: Mechanism of Action

The mechanism of Zelix (Fluconazole) is defined by its targeted intervention in the fungal cell's critical metabolic machinery, resulting in the inhibition of fungal cell growth and replication.


Targeting the Fungal Enzyme: Lanosterol 14-alpha Demethylase

The drug acts within the domain of enzyme-mediated signaling by selectively binding to and inhibiting lanosterol 14-alpha demethylase (CYP51). This inhibition initiates a molecular cascade that prevents the formation of ergosterol, a primary cell membrane sterol, resulting in altered membrane structure. The coordination bond between the drug's triazole nitrogen and the heme iron of the enzyme dictates this selective molecular action.


Pathway Disruption and Cell Membrane Failure

Fluconazole modulates key pathways associated with cell membrane homeostasis. The resulting ergosterol depletion and accumulation of toxic 14-methylated sterols fundamentally destabilize the fungal cell membrane's structure and function. This physiological consequence restricts the pathogen’s capacity for cellular division and replication.


Mechanistic Constraints and Fungal Resistance

The drug's activity is constrained by biological counter-mechanisms developed by the fungus. This typically involves genetic mutations that reduce the drug's binding affinity to the CYP51 enzyme, or the activation of efflux pumps which actively transport the drug out of the cell, reducing its effective concentration at the target site.

Dosage and Administration Information

Instruction Map: How to use Zelix — Official Administration Guidelines

Field Content
Route of administration: Zelix (Fluconazole) is administered through Oral intake (Capsules, Tablets, or Suspension) or by Intravenous (IV) Infusion.
Dosing schedule: A loading dose—typically double the maintenance amount—is often given on the first day of multi-dose regimens. Maintenance doses range from 50 mg to 400 mg once daily, with 800 mg cited for severe systemic infections.
Timing in relation to meals (if applicable): The medicine can be taken with or without food.
Preparation requirements (if applicable): The oral suspension must be shaken well before measurement. The IV solution is ready-to-use for infusion.
Age-group administration rules: Pediatric dosing is calculated based on body weight (mg/kg). Renal Impairment requires a 50% dose reduction for CrCl le 50 mL/min after the loading dose.
Special procedural conditions: IV infusion must not exceed a rate of 10 mL/minute (le 200 mg/hour). The daily dose remains unchanged when switching between the oral and intravenous routes.

Instruction Classifications (High-Level)

Field Content
Administration method type: Systemic (Oral and Intravenous).
Frequency pattern: Once daily (Standard); Intermittent (Once weekly); Single dose; Long-term maintenance.
Use-context constraints: Mandatory dose adjustment for renal impairment; Weight-based pediatric dosing; Time-defined treatment courses.

Connection to the Overall Use Protocol

The official instructions define a standardized protocol that structures administration around achieving rapid systemic concentrations through a loading dose and maintaining consistent levels with once-daily dosing. This framework establishes specific maintenance dose ranges and includes mandatory adjustments based on the patient’s renal function and age to standardize the medication’s use across varied clinical contexts.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Zelix

Evidence for Use in Invasive Fungal Infections

Zelix (Fluconazole) was studied in research contexts involving serious systemic fungal infections, most notably Candidemia (fungus in the bloodstream) and Cryptococcal Meningitis (infection of the brain lining). Research in these areas primarily includes Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews that compare different treatment regimens. Studies explored outcomes related to systemic or functional imbalance, such as patient survival rates and the mycological clearance of the fungus from the blood or cerebrospinal fluid (CSF).

Research examined outcomes for Candidemia across various patient groups. Data show patterns related to fungal clearance where using the drug as a single agent for the initial treatment phase was associated with a lower rate of fungal clearance measured in some studies compared to combination therapies. There is limited information for long-term outcomes beyond the initial treatment phase.


Evidence for Use in Mucosal and Localized Candidiasis

Studies explored the use of Zelix for localized conditions such as Oropharyngeal (thrush), Esophageal, and Vulvovaginal Candidiasis. The research examined short-term symptom changes and outcomes linked to inflammatory or irritative states and physical discomfort.

Studies monitored symptom and fungal clearance during the observed treatment periods for uncomplicated mucosal infections. Research describes how patients reported their experience with localized discomfort. Key limitations noted in the research include that many historical studies concentrated on specific patient cohorts, meaning results apply only to the populations studied. Data are still emerging regarding outcomes for infections caused by less common species of Candida.


Long-Term Studies and Maintenance Evidence

Research explored the role of Zelix in long-term suppression, particularly in managing the risk of relapse or recurrence of serious infections. Data show patterns related to recurrence when continuous therapy was observed in some studies compared to episodic treatment in certain susceptible populations. There is limited information for long-term outcomes regarding the general durability of the response across all indications after continuous use is discontinued. Scientific literature also highlights an ongoing discussion about the risk of certain fungal strains developing non-susceptible patterns measured during long-term maintenance treatment.

Key Studies & References

  1. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (IDSA)
  2. Evaluation of Fluconazole versus Echinocandins for Treatment of Candidemia Caused by Susceptible Common Candida Species: A Propensity Score Matching Analysis

Frequently Asked Questions (FAQ)

Common questions about Zelix (FAQ)

Q: What is the main difference between Zelix and other medicines for the same condition?

A: Regulatory and scientific literature notes that Zelix is distinguished from some older antifungal medicines by its high oral absorption.

This key feature allows it to be easily taken by mouth and achieve wide distribution throughout body fluids, including the cerebrospinal fluid.

Q: Does Zelix cause tiredness or fatigue?

A: Official safety information includes common nervous system effects such as dizziness and headache.

While fatigue and unusual weakness are not common, they are noted in official safety information in the context of rare but serious reactions, such as severe liver injury or low adrenal gland function.

Q: Can Zelix be taken at the same time as vitamin supplements?

A: Official guidance notes that patients are advised to inform their healthcare professional about all vitamins and supplements being used.

There is limited specific data on interactions between Zelix and supplements because they are not subject to the same strict regulatory testing requirements as prescription drugs.

Q: Are there known interactions between Zelix and herbal remedies?

A: Official guidance notes that patients are advised to inform their healthcare professional about any herbal remedies being used.

Similar to supplements, there is limited specific data on interactions, as herbal remedies are not tested under the same regulatory requirements as prescription medicines.

Q: Are there any mental or mood-related changes associated with Zelix?

A: Regulatory documents list central nervous system effects, including dizziness and headache, which affect alertness and mood.

More serious effects like seizures have been reported, and some studies have noted anxiety among the reported effects in specific patient populations.

Q: Can Zelix affect performance of daily tasks like driving?

A: Official information states that Zelix may cause dizziness or seizures.

A person's ability to drive or operate machinery may be affected by the medicine's effects. The regulatory document suggests awaiting certainty of the drug's effect before performing these tasks.

Q: What should a patient know about the research supporting Zelix?

A: Research supporting Zelix primarily includes Randomized Controlled Trials that examine treatment outcomes.

These studies investigate factors like patient survival rates and the clearance of the fungus from the body's systems, as documented in scientific literature.

Q: Is Zelix used for conditions other than what the label says?

A: Official regulatory documents define the approved conditions for which Zelix is indicated, such as specific fungal infections.

The official label does not provide information on or recommendations for using the medicine for conditions outside of these approved indications.

Q: Why is Zelix prescribed to certain people and not others?

A: Prescribing decisions are guided by the official label, which defines approved uses and lists specific factors that limit its use.

These factors include known drug interactions, documented hypersensitivity, or pre-existing conditions like severe liver or kidney impairment.

Q: How quickly can someone typically expect Zelix to start working?

A: Official patient information indicates that some individuals may notice initial changes during the first few days of treatment.

Depending on the dosage regimen, consistent medicine levels in the blood (known as steady-state concentrations) may take several days to reach, or be achieved more quickly with a loading dose.

Q: Are there any common lifestyle factors that affect how Zelix works?

A: Regulatory documents confirm the medicine can be taken with or without food because food does not significantly affect its absorption.

However, the official label advises avoidance of alcohol due to the potential for increased risk of liver damage.

Q: Is Zelix considered a long-term treatment?

A: The required duration of use for Zelix varies significantly depending on the condition being treated and its severity.

Treatment may range from a single dose for some conditions to a course lasting several weeks, months, or long term for preventing recurrence of serious infections, as guided by official advice.

Q: What happens if a dose of Zelix is forgotten?

A: Official patient guidance describes that taking a forgotten dose upon remembering is the suggested approach.

However, if it is close to the time of the next scheduled dose, patients are advised to skip the forgotten dose and not to double up on doses to make up for the missed one.

Q: How long does the main effect of Zelix last after taking a dose?

A: The duration the medicine remains in the body is described by its half-life, a pharmacological measure.

Official pharmacokinetics data reports the terminal plasma elimination half-life is approximately 30 hours, with a noted range of 20 to 50 hours.

Q: Are there differences in research evidence for Zelix across different patient groups?

A: Scientific literature confirms that clinical trials have historically focused on specific patient groups, such as those with weakened immune systems or pediatric populations.

The evidence profile is therefore based on outcomes observed within those specific studied populations, as described in official reports.

Q: What is the physical appearance of the Zelix medicine (color, shape, etc.)?

A: According to the official product information, the active ingredient is a white crystalline solid.

Different forms are available; for example, tablets often contain coloring agents such as FD&C red #40 aluminum lake, which determines the final appearance.

Q: Is the active substance in Zelix naturally occurring?

A: The active substance, Fluconazole, is chemically classified as a synthetic triazole antifungal agent.

This means the compound is engineered in a lab and is not a naturally occurring substance.

Q: Do clinical trial reports on Zelix show any long-term safety data?

A: While the original trials supporting initial approval did not focus on patients requiring very long-term treatment, subsequent research has examined this.

Studies have been conducted to look at the safety profile for extended use in specific populations, noting effects such as dry skin and hair loss.

Q: Can Zelix cause problems with the liver or kidneys?

A: Official documents state that Zelix is associated with a rare risk of severe liver toxicity.

For the kidneys, dose adjustment is mandatory for patients with existing renal impairment because the drug is primarily cleared from the body through the kidneys.

Q: Does the time of day Zelix is taken matter?

A: The medicine is generally recommended to be taken once daily.

Official patient instructions suggest taking the capsule or liquid at the same time each day to help maintain a consistent presence of the medicine in the body.

Q: Do studies suggest Zelix is safe for people over the age of 65?

A: Official information indicates that the pharmacokinetics (how the body handles the drug) are different in the elderly population, with a longer half-life observed.

Use in older adults is conditional on assessing renal function and requires careful monitoring, as detailed in regulatory documents.

How should Zelix be stored and disposed of?

Storage and Disposal of Zelix

Official regulatory guidelines detail specific requirements for storing and disposing of Zelix (Fluconazole) to maintain product stability and ensure public safety.

Storage Requirement Condition
Temperature Store at controlled room temperature, typically 20°C to 25°C.
Protection Keep in the original container, tightly closed, protected from moisture and excessive heat.
Stability The reconstituted oral suspension must be discarded after 14 days; do not freeze the suspension.
Safety Must be kept out of the sight and reach of children.

Unused or expired Zelix should be disposed of by following specific procedures. The preferred method is to utilize an authorized drug take-back program. If a take-back program is unavailable, the medicine should be mixed with an undesirable substance, placed in a sealed container, and then thrown into the household trash, avoiding disposal via wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zelix found in:

A-Z Index: